
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>record_id</th><th>visit</th><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Allopurinol</td><td>The therapeutic efficacy of Allopurinol can be decreased when used in
combination with Acetylsalicylic acid.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Apixaban</td><td>The risk or severity of adverse effects can be increased when Acetylsalicylic
acid is combined with Apixaban.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Bisoprolol</td><td>Acetylsalicylic acid may decrease the antihypertensive activities of Bisoprolol.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Dutasteride</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Dutasteride.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Furosemide</td><td>The risk or severity of increased serum creatinine can be increased when
Acetylsalicylic acid is combined with Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Quetiapine</td><td>The risk or severity of hypertension can be increased when Acetylsalicylic acid
is combined with Quetiapine.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Spironolactone</td><td>The therapeutic efficacy of Spironolactone can be decreased when used in
combination with Acetylsalicylic acid.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Tenofovir alafenamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Acetylsalicylic acid.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Tiotropium</td><td>Acetylsalicylic acid may decrease the excretion rate of Tiotropium which could
result in a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Acetylsalicylic acid</td><td>Vortioxetine</td><td>The risk or severity of bleeding can be increased when Vortioxetine is combined
with Acetylsalicylic acid.</td></tr><tr><td>RG09</td><td>1</td><td>Apixaban</td><td>Bisoprolol</td><td>The serum concentration of Apixaban can be increased when it is combined with
Bisoprolol.</td></tr><tr><td>RG09</td><td>1</td><td>Apixaban</td><td>Dutasteride</td><td>The metabolism of Apixaban can be decreased when combined with Dutasteride.</td></tr><tr><td>RG09</td><td>1</td><td>Apixaban</td><td>Vortioxetine</td><td>The metabolism of Vortioxetine can be decreased when combined with Apixaban.</td></tr><tr><td>RG09</td><td>1</td><td>Bisoprolol</td><td>Allopurinol</td><td>Allopurinol may decrease the excretion rate of Bisoprolol which could result in
a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Dutasteride</td><td>Bisoprolol</td><td>Dutasteride may decrease the antihypertensive activities of Bisoprolol.</td></tr><tr><td>RG09</td><td>1</td><td>Dutasteride</td><td>Vortioxetine</td><td>The risk or severity of hypertension can be increased when Dutasteride is
combined with Vortioxetine.</td></tr><tr><td>RG09</td><td>1</td><td>Esomeprazole</td><td>Allopurinol</td><td>The excretion of Allopurinol can be decreased when combined with Esomeprazole.</td></tr><tr><td>RG09</td><td>1</td><td>Esomeprazole</td><td>Apixaban</td><td>The metabolism of Apixaban can be decreased when combined with Esomeprazole.</td></tr><tr><td>RG09</td><td>1</td><td>Esomeprazole</td><td>Tenofovir alafenamide</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Esomeprazole.</td></tr><tr><td>RG09</td><td>1</td><td>Esomeprazole</td><td>Vortioxetine</td><td>The metabolism of Vortioxetine can be decreased when combined with Esomeprazole.</td></tr><tr><td>RG09</td><td>1</td><td>Folic acid</td><td>Allopurinol</td><td>Folic acid may decrease the excretion rate of Allopurinol which could result in
a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Folic acid</td><td>Bisoprolol</td><td>Folic acid may decrease the excretion rate of Bisoprolol which could result in a
higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Folic acid</td><td>Tenofovir alafenamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Folic acid.</td></tr><tr><td>RG09</td><td>1</td><td>Folic acid</td><td>Vortioxetine</td><td>Folic acid may decrease the excretion rate of Vortioxetine which could result in
a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Furosemide</td><td>Allopurinol</td><td>The risk or severity of adverse effects can be increased when Furosemide is
combined with Allopurinol.</td></tr><tr><td>RG09</td><td>1</td><td>Furosemide</td><td>Bisoprolol</td><td>Bisoprolol may increase the hypotensive activities of Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Furosemide</td><td>Dutasteride</td><td>Dutasteride may decrease the antihypertensive activities of Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Furosemide</td><td>Folic acid</td><td>Furosemide may decrease the excretion rate of Folic acid which could result in a
higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Furosemide</td><td>Tenofovir alafenamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Furosemide</td><td>Vortioxetine</td><td>Vortioxetine may decrease the antihypertensive activities of Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Allopurinol</td><td>Allopurinol may decrease the excretion rate of Quetiapine which could result in
a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Apixaban</td><td>The metabolism of Apixaban can be decreased when combined with Quetiapine.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Bisoprolol</td><td>Quetiapine may increase the hypotensive activities of Bisoprolol.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Dutasteride</td><td>The risk or severity of hypertension can be increased when Dutasteride is
combined with Quetiapine.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Folic acid</td><td>Folic acid may decrease the excretion rate of Quetiapine which could result in a
higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Furosemide</td><td>Quetiapine may increase the hypotensive activities of Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Spironolactone</td><td>Quetiapine may increase the hypotensive activities of Spironolactone.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Tenofovir alafenamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Quetiapine.</td></tr><tr><td>RG09</td><td>1</td><td>Quetiapine</td><td>Vortioxetine</td><td>The risk or severity of adverse effects can be increased when Vortioxetine is
combined with Quetiapine.</td></tr><tr><td>RG09</td><td>1</td><td>Raltegravir</td><td>Esomeprazole</td><td>Esomeprazole can cause an increase in the absorption of Raltegravir resulting in
an increased serum concentration and potentially a worsening of adverse effects.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Allopurinol</td><td>The excretion of Allopurinol can be decreased when combined with Rosuvastatin.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Apixaban</td><td>The metabolism of Apixaban can be decreased when combined with Rosuvastatin.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Esomeprazole</td><td>The excretion of Rosuvastatin can be decreased when combined with Esomeprazole.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Furosemide</td><td>The excretion of Rosuvastatin can be decreased when combined with Furosemide.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Raltegravir</td><td>The risk or severity of myopathy and rhabdomyolysis can be increased when
Raltegravir is combined with Rosuvastatin.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Tenofovir alafenamide</td><td>The excretion of Tenofovir alafenamide can be decreased when combined with
Rosuvastatin.</td></tr><tr><td>RG09</td><td>1</td><td>Rosuvastatin</td><td>Vortioxetine</td><td>The metabolism of Vortioxetine can be decreased when combined with Rosuvastatin.</td></tr><tr><td>RG09</td><td>1</td><td>Silodosin</td><td>Apixaban</td><td>The serum concentration of Apixaban can be increased when it is combined with
Silodosin.</td></tr><tr><td>RG09</td><td>1</td><td>Silodosin</td><td>Bisoprolol</td><td>The risk or severity of orthostatic hypotension and dizziness can be increased
when Bisoprolol is combined with Silodosin.</td></tr><tr><td>RG09</td><td>1</td><td>Silodosin</td><td>Furosemide</td><td>The risk or severity of orthostatic hypotension and dizziness can be increased
when Furosemide is combined with Silodosin.</td></tr><tr><td>RG09</td><td>1</td><td>Silodosin</td><td>Quetiapine</td><td>Quetiapine may increase the orthostatic hypotensive, hypotensive, and
antihypertensive activities of Silodosin.</td></tr><tr><td>RG09</td><td>1</td><td>Silodosin</td><td>Spironolactone</td><td>The risk or severity of orthostatic hypotension and dizziness can be increased
when Spironolactone is combined with Silodosin.</td></tr><tr><td>RG09</td><td>1</td><td>Spironolactone</td><td>Allopurinol</td><td>Spironolactone may increase the excretion rate of Allopurinol which could result
in a lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>RG09</td><td>1</td><td>Spironolactone</td><td>Bisoprolol</td><td>The risk or severity of hyperkalemia can be increased when Bisoprolol is
combined with Spironolactone.</td></tr><tr><td>RG09</td><td>1</td><td>Spironolactone</td><td>Dutasteride</td><td>Dutasteride may decrease the antihypertensive activities of Spironolactone.</td></tr><tr><td>RG09</td><td>1</td><td>Spironolactone</td><td>Folic acid</td><td>Spironolactone may increase the excretion rate of Folic acid which could result
in a lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>RG09</td><td>1</td><td>Spironolactone</td><td>Vortioxetine</td><td>Vortioxetine may decrease the antihypertensive activities of Spironolactone.</td></tr><tr><td>RG09</td><td>1</td><td>Tenofovir alafenamide</td><td>Allopurinol</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Allopurinol.</td></tr><tr><td>RG09</td><td>1</td><td>Tenofovir alafenamide</td><td>Bisoprolol</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Bisoprolol.</td></tr><tr><td>RG09</td><td>1</td><td>Tenofovir alafenamide</td><td>Vortioxetine</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Vortioxetine.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Allopurinol</td><td>Allopurinol may decrease the excretion rate of Tiotropium which could result in
a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Bisoprolol</td><td>Bisoprolol may decrease the excretion rate of Tiotropium which could result in a
higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Folic acid</td><td>Folic acid may decrease the excretion rate of Tiotropium which could result in a
higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Furosemide</td><td>Furosemide may decrease the excretion rate of Tiotropium which could result in a
higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Quetiapine</td><td>The risk or severity of adverse effects can be increased when Quetiapine is
combined with Tiotropium.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Spironolactone</td><td>Spironolactone may increase the excretion rate of Tiotropium which could result
in a lower serum level and potentially a reduction in efficacy.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Tenofovir alafenamide</td><td>The serum concentration of Tenofovir alafenamide can be increased when it is
combined with Tiotropium.</td></tr><tr><td>RG09</td><td>1</td><td>Tiotropium</td><td>Vortioxetine</td><td>Tiotropium may decrease the excretion rate of Vortioxetine which could result in
a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Vortioxetine</td><td>Allopurinol</td><td>Allopurinol may decrease the excretion rate of Vortioxetine which could result
in a higher serum level.</td></tr><tr><td>RG09</td><td>1</td><td>Vortioxetine</td><td>Bisoprolol</td><td>Vortioxetine may decrease the antihypertensive activities of Bisoprolol.</td></tr></tbody></table></div>
